MedTrace Logo

Safety and Effectiveness of Juvéderm® Volbella With Lidocaine Versus Restylane-L® for Lip Volume Enhancement

NCT01579305 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2019-01-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is evaluate lip fullness 3 months following treatment with Juvéderm® Volbella with Lidocaine or Restylane-L®

Conditions

  • Lip Volume Enhancement

Interventions

DEVICE

Juvéderm® Volbella with Lidocaine

Up to 4.0 mL at the discretion of the Investigator to achieve optimal results

DEVICE

Restylane-L®

Up to 4.0 mL at the discretion of the Investigator to achieve optimal results

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-06-30
Completion
2014-01-31

Countries

  • France
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01579305 on ClinicalTrials.gov